144 ·Filed Aug 12, 2026

ZLAB

Zai Lab Ltd
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001959173-26-005923
Actionable Insight • Neutral

This is a routine, small-dollar sale by a director of vested RSUs — no bearish signal. Monitor for any follow-on Form 4 filings to confirm execution, but no trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
ZLAB ▼ -5.18% at T+20d
NEUTRAL call ✗ call lost -5.18% · α vs SPY -3.28% · entry $25.49 → $24.17
Next anchor: T+60d in 5w
Latest observation: T+34 -5.95% FF3 residual α
Entry anchored
Aug 12, 10:42 AM ET
via 1-min bar
T+1d
+2.12%
call +2.12% · α +1.42%
$26.03
settled 7w ago
T+5d
+4.83%
call +4.83% · α +5.27%
$26.72
settled 6w ago
T+20d
-5.18%
call -5.18% · α -3.28%
$24.17
settled 22d ago
T+60d
—
call — · α —
—
in 5w

Price Chart

Loading chart...

Executive Summary

Director William Lis filed a Form 144 to sell 8,506 American Depositary Shares (ADS) valued at approximately $212,650, acquired via restricted stock vesting on 06/29/2024. This is a routine, small-dollar sale by a director of shares obtained as compensation over two years ago — not a conviction sell. The filing signals intent to liquidate a modest position, likely for personal financial planning, and carries no material negative signal for the stock.

Key Facts

  • Director William Lis filed Form 144 to sell 8,506 ADS of Zai Lab Ltd.
  • Estimated sale value: ~$212,650 (based on ~$25.00/share).
  • Shares were acquired via restricted stock vesting on 06/29/2024 — held over 2 years.
  • The sale is small relative to Zai Lab's $2.9B market cap (~0.007% of market cap).
  • Broker: Fidelity Brokerage Services LLC; sale intended on NASDAQ.

Financial Impact

~$212,650 sale by a director — immaterial relative to $2.9B market cap

insider holdings

Risk Factors

  • Insider could sell additional shares in the future if this is part of a broader plan
  • No material risk — sale is small and from compensation

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
79% bullish (14 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (ZLAB) — Batch item 10001959173-26-005923
Document: 0001959173-26-005923-index.html0001959173-26-005923
Document: 0001959173-26-005923.txt0001959173-26-005923
144 Filing (ZLAB) — Batch item 40001959173-26-005923
Document: 0001959173-26-005923-index.html0001959173-26-005923
Document: 0001959173-26-005923.txt0001959173-26-005923
20 reports for ZLAB
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +13.13%May 7, 2026
Filters
Rows
Reports for ZLAB — sortable, filterable
TypeNow
Aug 21, 2026
6w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.01 $26.08▲ +0.27%▼ −0.20%$24.33 (−6.46%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.03 $26.02▼ −0.04%▲ +1.93%$24.33 (−6.53%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$26.03 $26.02▼ −0.04%▲ +1.93%$24.33 (−6.53%)
Aug 12, 2026
7w ago
144
NEUTRAL ★ 2/10
$25.49 $26.72▲ +4.83%▲ +5.27%$24.33 (−4.55%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$19.15 $19.35▲ +1.04%▲ +0.78%$24.33 (+27.05%)
Jun 29, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$19.00 $19.08▲ +0.42%▼ −0.18%$24.33 (+28.05%)
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 5/10
$17.64 $17.88▼ −1.36%▼ −0.93%$24.33 (−37.93%)
May 21, 2026
19w ago
8-K
NEUTRAL ★ 4/10
$18.61 $17.09▼ −8.17%▼ −9.83%$24.33 (+30.74%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$18.81 $18.69▼ −0.64%▼ −1.88%$24.33 (+29.35%)
May 19, 2026
19w ago
Insider Cluster
BEARISH ★ 6/10
$18.81 $18.69▲ +0.64%▲ +1.88%$24.33 (−29.35%)
Showing 10 of 20

US Market Status

Market Closed — Opens Mon (39h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access